Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. ISPC
stocks logo

ISPC

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2024Q3
FY2024Q4
FY2025Q1
2.95M
+6.09%
--
--
2.98M
+15.61%
--
--
2.55M
+11.18%
--
--
Estimates Revision
The market is revising No Change the revenue expectations for iSpecimen Inc. (ISPC) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -43.08%.
Revenue Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
Stock Price
Go Down
down Image
-43.08%
In Past 3 Month

Valuation Metrics

The current forward P/E ratio for iSpecimen Inc (ISPC.O) is -0.03, compared to its 5-year average forward P/E of -13.71. For a more detailed relative valuation and DCF analysis to assess iSpecimen Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-13.71
Current PE
-0.03
Overvalued PE
41.56
Undervalued PE
-68.98

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-1.50
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
2.25
Undervalued EV/EBITDA
-5.25

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.46
Current PS
0.00
Overvalued PS
3.27
Undervalued PS
-0.36
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

ISPC News & Events

Events Timeline

(ET)
2025-07-24
08:41:24
iSpecimen prices 5.7M shares at 70c in underwritten public offering
select
2024-11-07 (ET)
2024-11-07
06:49:54
iSpecimen releases cancer biospecimen offering
select
2024-11-07
06:10:18
iSpecimen reports Q3 EPS ($2.10) vs ($4.66) last year
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
9.5
09-10Benzinga
Oracle Shares Surge Nearly 30%; Check Out 20 Stocks Making Moves in Premarket Trading

  • Oracle Corporation Earnings Report: Oracle's shares rose 29.6% in pre-market trading despite reporting first-quarter earnings of $1.47 per share, slightly below the analyst estimate of $1.48, and revenue of $14.92 billion, missing the expected $15.03 billion but showing growth from $13.3 billion year-over-year.

  • Pre-Market Stock Movements: Several stocks saw significant pre-market trading movements, with Marwynn Holdings gaining 310.6% and Antelope Enterprise Holdings rising 238%, while QMMM Holdings and Epsium Enterprise experienced sharp declines of 60% and 54.4%, respectively.

[object Object]
Preview
4.5
09-08Benzinga
Robinhood Shares Surge Over 7%; Check Out 20 Stocks Making Moves in Premarket Trading

  • Robinhood's Market Movement: Robinhood Markets, Inc. shares surged 7.4% in pre-market trading after being announced as a replacement for Caesars Entertainment in the S&P 500, effective September 22.

  • Other Notable Gainers: Several stocks saw significant pre-market gains, including Eightco Holdings (up 142.1%), Gyrodyne (up 82.1%), and Forward Industries (up 78.8%).

  • Pre-Market Losers: Citius Oncology experienced a 25% drop, while MEI Pharma and CNFinance also saw declines of 19.3% and 18.8%, respectively, in pre-market trading.

  • Market Overview: The article provides a snapshot of various stocks' performances, highlighting both significant gainers and losers in the pre-market trading session.

[object Object]
Preview
9.5
09-05Benzinga
Docusign Shares Surge Over 8%; Check Out 20 Stocks Making Moves in Premarket Trading

  • DocuSign's Financial Performance: DocuSign Inc. shares surged 8.5% in pre-market trading after reporting Q2 earnings of 92 cents per share, exceeding estimates, and raising FY26 sales guidance above expectations.

  • Other Notable Stock Movements: Several stocks experienced significant pre-market trading changes, with Hour Loop, Inc. gaining 75.1% and American Outdoor Brands Inc. falling 18.4% after disappointing earnings.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is iSpecimen Inc (ISPC) stock price today?

The current price of ISPC is 0.4859 USD — it has increased 6.58 % in the last trading day.

arrow icon

What is iSpecimen Inc (ISPC)'s business?

iSpecimen Inc. is a technology-driven company. The Company addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company’s iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.

arrow icon

What is the price predicton of ISPC Stock?

Wall Street analysts forecast ISPC stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ISPC is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is iSpecimen Inc (ISPC)'s revenue for the last quarter?

iSpecimen Inc revenue for the last quarter amounts to 106.59K USD, decreased -96.00 % YoY.

arrow icon

What is iSpecimen Inc (ISPC)'s earnings per share (EPS) for the last quarter?

iSpecimen Inc. EPS for the last quarter amounts to -0.48 USD, decreased -77.14 % YoY.

arrow icon

What changes have occurred in the market's expectations for iSpecimen Inc (ISPC)'s fundamentals?

The market is revising No Change the revenue expectations for iSpecimen Inc. (ISPC) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -43.08%.
arrow icon

How many employees does iSpecimen Inc (ISPC). have?

iSpecimen Inc (ISPC) has 24 emplpoyees as of December 05 2025.

arrow icon

What is iSpecimen Inc (ISPC) market cap?

Today ISPC has the market capitalization of 4.65M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free